<DOC>
	<DOCNO>NCT02348905</DOCNO>
	<brief_summary>ACTHAR gel efficacy treatment cutaneous sarcoidosis</brief_summary>
	<brief_title>ACTHAR Gel Cutaneous Sarcoidosis : An Open Label Trial</brief_title>
	<detailed_description>Sarcoidosis multisystem granulomatous disease unknown cause . Although sarcoidosis commonly affect lung3 , may affect organ . Although corticosteroid recognize drug choice sarcoidosis , ACTH drug FDA-approved disorder . However , limited data efficacy ACTH condition . Presently , corticosteroid consider drug choice treatment cutaneous sarcoidosis . However , ACTHER GEL obvious anti-inflammatory effect result corticosteroid production , may also activate melanocortin receptor . The melanocortin system powerful anti-inflammatory property may beneficial treatment cutaneous sarcoidosis .</detailed_description>
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<mesh_term>Melanocyte-Stimulating Hormones</mesh_term>
	<mesh_term>beta-Endorphin</mesh_term>
	<criteria>1 . Patients must biopsyproven sarcoidosis . 2. ) Patients active cutaneous sarcoidosis two active lesion stable therapy therapy least two month AND/OR b ) Patients active cutaneous sarcoidosis lupus pernio lesion stable therapy therapy least two month . A maximum 5 patient may enrol fulfil criterion b ) . 3 . Both lesion must SASI induration score &gt; 1 SASI induration + erythema score &gt; 2 . 4 . If two lesion present , one must &gt; 1cm diameter subject must willing biopsied . The second lesion must least 0.5 cm diameter . 5 . If subject lupus pernio facial lesion , one need least 0.5 cm diameter . 1 . Previous toxic allergic reaction ACTHAR gel 2 . The presence another skin condition addition sarcoidosis would interfere assessment sarcoidosis skin lesion . 3 . Uncontrolled hypertension . 4 . Uncontrolled diabetes . 5 . Active infection . 6 . A medical condition , opinion investigator would place subject significant risk administer ACTHAR gel .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>